Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Weekly low dose CPT-11 for multiple lung metastases of colon cancer on an out-patient treatment: a case report].
Sasaki K, Takasaka H, Kawasaki H, Oono K, Nakayama I, Matsunaga T, Takaoka A, Aoki S, Hamamatsu C, Hirayama T, Nakagawa N, Shibata K, Yabana T, Yamamoto Y, Hirata K. Sasaki K, et al. Among authors: yamamoto y. Nihon Shokakibyo Gakkai Zasshi. 2001 Feb;98(2):157-61. Nihon Shokakibyo Gakkai Zasshi. 2001. PMID: 11235190 Japanese. No abstract available.
Muscle metastases as initial manifestation of lung cancer.
Haraguchi N, Yamamoto Y, Sasaki K, Satoh H, Sekizawa K. Haraguchi N, et al. Among authors: yamamoto y. Clin Oncol (R Coll Radiol). 2004 Dec;16(8):586-7. doi: 10.1016/j.clon.2004.09.006. Clin Oncol (R Coll Radiol). 2004. PMID: 15630861 No abstract available.
Preoperative chemoradiotherapy using tegafur/uracil, oral leucovorin, and irinotecan (TEGAFIRI) followed by oxaliplatin-based chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: the study protocol for a phase II trial.
Abe S, Kawai K, Nozawa H, Sasaki K, Murono K, Emoto S, Yokoyama Y, Matsuzaki H, Nagai Y, Yoshioka Y, Shinagawa T, Sonoda H, Yamamoto Y, Oba K, Ishihara S. Abe S, et al. Among authors: yamamoto y. BMC Cancer. 2023 May 17;23(1):450. doi: 10.1186/s12885-023-10941-z. BMC Cancer. 2023. PMID: 37198556 Free PMC article.
Association of body mass index and tumor response in metastatic urothelial carcinoma treated with enfortumab vedotin: data from the ULTRA-Japan consortium.
Uchimoto T, Iwatsuki K, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Hashimoto M, Minami T, Yamamoto Y, Yamazaki S, Takai T, Sakamoto M, Nakajima Y, Nishimura K, Maenosono R, Tsujino T, Nakamura K, Fukushima T, Nishio K, Yoshikawa Y, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Fujita K, Kimura T, Ohno Y, Shiroki R, Azuma H. Uchimoto T, et al. Among authors: yamamoto y. Int J Clin Oncol. 2025 Jan 31. doi: 10.1007/s10147-025-02709-1. Online ahead of print. Int J Clin Oncol. 2025. PMID: 39890750
12,353 results
You have reached the last available page of results. Please see the User Guide for more information.